Key result
Chemotherapy and immunotherapy drive marked regression of metastatic right atrial angiosarcoma in a 28-year-old man.
Case Report (n=1)
No
Chemotherapy and immunotherapy resulted in a marked decrease of primary cardiac angiosarcoma and pulmonary metastases in a single patient.
Answers are grounded in this paper and cite their sources.
Suggests potential role for chemo-immunotherapy in cardiac angiosarcoma; hypothesis-generating and should not yet change practice.
This reports outlines a rare case of primary right atrial angiosarcoma with multiple metastases. Multimodality imaging and histopathology confirmed the diagnosis of primary cardiac angiosarcoma and multiple metastases. We present the details of the presentation, multimodality imaging findings, and clinical management. The patient was followed up by cardiac MRI (CMRI) 2 months after therapy, the cardiac tumor and pulmonary metastases decreased markedly. Up to now, the patient has undergone four cycles of chemotherapy and immunotherapy.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) conducted a case report in Primary cardiac angiosarcoma with multiple metastases (n=1). Chemotherapy and immunotherapy (epirubicin, ifosfamide, pembrolizumab) and palliative radiotherapy was evaluated on Tumor response. In a 28-year-old man with primary right atrial angiosarcoma and multiple metastases, treatment with chemotherapy and immunotherapy resulted in marked regression of the cardiac tumor and pulmonary metastases.
Synapse has enriched 10 related papers. Consider them for comparative context: